Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82

Asian Paints Q2FY19E Result Expectation

India Infoline News Service Oct-22-2018

Management commentary on volume growth and demand scenario post-GST rate cut in both rural and urban markets.

4 Stock Recommendations for October 22 to October 26, 2018

India Infoline News Service Oct-22-2018

Stock recommendations to strengthen one's portfolio.

What not to miss today

India Infoline News Service Oct-22-2018

Here are the important news to watch out for today.

SGX Nifty indicates flat opening; focus on Q2 earnings

India Infoline News Service Oct-22-2018

For today, expect 10,250 levels to hold as rupee holding gains closer to 73 could inspire some confidence along with better than expected earnings from large corporates like HDFC bank.

Strides gets final approval for gNeurontin

India Infoline News Service Oct-22-2018

Strides' Gabapentin Capsules is a generic version of Pfizer's Neurontin Capsules, the market for which is ~$270mn.

Lupin gets positive CHMP opinion for its orphan drug NaMuscla

India Infoline News Service Oct-21-2018

NaMuscla is indicated for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders. The company expects the product to get final approval within the next three months.

Indian Equities News